The U.S. Food and Drug Administration has approved the blood-thinning drug Effient tablets (prasugrel) to reduce the risk of blood clots from forming in patients who undergo angioplasty, a common procedure to unblock a clogged coronary artery.
Excerpt from:
FDA Approves Effient to Reduce the Risk of Heart Attack in Angioplasty Patients
The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, has filed a complaint for permanent injunction against Quality Formulation Laboratories, Inc., American Sports Nutrition Inc., Sports Nutrition International LLC and Mohamed S.
See more here:
FDA Takes Enforcement Action Against Three New Jersey Dietary Supplement and Protein Powder Manufacturers
Lewis Laboratories International, Ltd. is voluntarily recalling Weigh Down Chocolate Flavor Nutrition Drink Mix as a precautionary measure, Lot Numbers: 170C110 Best By Date 12/16/2011, 170C111 Best By Date 03/12/2012, 170C112 Best By Date 4/28/2012 and 170C113 Best By Date 6/5/2012 – Net Wt. 16 oz
See the article here:
Lewis Laboratories International, Ltd. Recalls Weigh Down Chocolate Flavor Nutrition Drink Mix Because of Possible Health Risk
Premier Nutrition Announces Precautionary, Voluntary Nationwide Recall of selected ODYSSEY Branded Bars Containing Peanuts Due to Possible Health Risk
See the article here:
Premier Nutrition Announces Precautionary, Voluntary Nationwide Recall of selected ODYSSEY Branded Bars Containing Peanuts Due to Possible Health Risk